Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check24 days agoChange DetectedAdded a site-wide notice about potential data delays due to a lapse in government funding and ongoing status updates; included a new revision tag (v3.4.1) and removed the previous revision (v3.4.0).SummaryDifference0.3%

- Check31 days agoChange DetectedA glossary toggle was added, and the labels were updated to 'Last Update Submitted that Met QC Criteria' with capitalization; 'No FEAR Act Data' was added, and the revision was bumped to v3.4.0 (replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4).SummaryDifference0.1%

- Check45 days agoChange DetectedPage revision updated to v3.3.4; the previous revision v3.3.3 was replaced.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a 'Locations' section with study sites across CA, CO, FL, GA, IN, MD, MN, NY, TX, VT, NSW, QLD, and VIC. This helps users identify enrollment sites.SummaryDifference1.0%

- Check88 days agoChange DetectedThe page header now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. This is a metadata update that does not affect study content or user-facing details.SummaryDifference0.0%

Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.